Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Carbamazepine
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 100 mg/5 mL
- Dosage form
- Suspension
- Pack
- 120ml
- Registration no.
- 031085
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-27 02:57
Manufacturer
Adamjee Pharmaceuticals (Pvt) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 201.96 to 211.94 (+4.9%) between 1 Jul 2025 and 20 Aug 2026 · 2 official price records · pack 120ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. EPICAR susp 100 mg/5 mL, 120ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/epicar-susp-100-mg-5-ml-031085-120ml-adamjee-pharmaceuticals-pvt-ltd/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 211.94 | 2026-08-20 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 201.96 | 2025-07-01 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 031085Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
